These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11760212)

  • 1. Preclinical and clinical pharmacology of biotherapeutic agents: Saccharomyces boulardii.
    Periti P; Tonelli F
    J Chemother; 2001 Oct; 13(5):473-93. PubMed ID: 11760212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotherapeutics and biotherapy of surgical enteropathies.
    Periti P; Tonelli F
    Dig Liver Dis; 2002 Sep; 34 Suppl 2():S87-97. PubMed ID: 12408450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: yeast as probiotics -- Saccharomyces boulardii.
    Czerucka D; Piche T; Rampal P
    Aliment Pharmacol Ther; 2007 Sep; 26(6):767-78. PubMed ID: 17767461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Saccharomyces boulardii on intestinal mucosa.
    Buts JP; De Keyser N
    Dig Dis Sci; 2006 Aug; 51(8):1485-92. PubMed ID: 16838119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics and mechanisms of their curative action.
    Bondarenko VM; Chuprinina RP; Aladysheva ZhI; Matsulevich TV
    Eksp Klin Gastroenterol; 2004; (3):83-7, 105. PubMed ID: 15560409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Saccharomyces boulardii on necrotizing enterocolitis or sepsis in very low birth weight infants: a randomised controlled trial.
    Serce O; Benzer D; Gursoy T; Karatekin G; Ovali F
    Early Hum Dev; 2013 Dec; 89(12):1033-6. PubMed ID: 24041815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children.
    Szajewska H; Skórka A; Dylag M
    Aliment Pharmacol Ther; 2007 Feb; 25(3):257-64. PubMed ID: 17269987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Too fast, too soon to call it "probiotic".
    Miniello VL; Colasanto A; Diaferio L; Galizia IS; Jablonska J; Lauriero MA; Lieggi MS; Raimondi G; Santoiemma V; Sarcinella G; Simone R; Torrente P
    Minerva Pediatr; 2010 Jun; 62(3 Suppl 1):105-7. PubMed ID: 21089729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-hypercholesterolemic effect of Saccharomyces boulardii in the hamster.
    Girard P; Pansart Y; Verleye M
    Pharmacology; 2014; 94(5-6):239-44. PubMed ID: 25427779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotic agent Saccharomyces boulardii reduces the incidence of lung injury in acute necrotizing pancreatitis induced rats.
    Karen M; Yuksel O; Akyürek N; Ofluoğlu E; Cağlar K; Sahin TT; Paşaoğlu H; Memiş L; Akyürek N; Bostanci H
    J Surg Res; 2010 May; 160(1):139-44. PubMed ID: 19375719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the probiotic agent Saccharomyces Boulardii on the DNA damage in acute necrotizing pancreatitis induced rats.
    Sahin T; Aydin S; Yüksel O; Bostanci H; Akyürek N; Memiş L; Başaran N
    Hum Exp Toxicol; 2007 Aug; 26(8):653-61. PubMed ID: 17884953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saccharomyces boulardii for prevention of necrotizing enterocolitis in preterm infants: a randomized, controlled study.
    Demirel G; Erdeve O; Celik IH; Dilmen U
    Acta Paediatr; 2013 Dec; 102(12):e560-5. PubMed ID: 24028629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular tools for differentiating probiotic and clinical strains of Saccharomyces cerevisiae.
    Posteraro B; Sanguinetti M; Romano L; Torelli R; Novarese L; Fadda G
    Int J Food Microbiol; 2005 Sep; 103(3):295-304. PubMed ID: 16099314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The probiotic Saccharomyces boulardii upgrades intestinal digestive functions by several mechanisms.
    Buts JP
    Acta Gastroenterol Belg; 2009; 72(2):274-6. PubMed ID: 19637791
    [No Abstract]   [Full Text] [Related]  

  • 15. Probiotics, prebiotics, and synbiotics.
    de Vrese M; Schrezenmeir J
    Adv Biochem Eng Biotechnol; 2008; 111():1-66. PubMed ID: 18461293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotic and prebiotic influence beyond the intestinal tract.
    Lenoir-Wijnkoop I; Sanders ME; Cabana MD; Caglar E; Corthier G; Rayes N; Sherman PM; Timmerman HM; Vaneechoutte M; Van Loo J; Wolvers DA
    Nutr Rev; 2007 Nov; 65(11):469-89. PubMed ID: 18038940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotics.
    Gupta V; Garg R
    Indian J Med Microbiol; 2009; 27(3):202-9. PubMed ID: 19584499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biotherapeutic use of yeasts--importance of probiotic products].
    Ghindea R; Csutak O; Stoica I; Vassu T
    Bacteriol Virusol Parazitol Epidemiol; 2008; 53(1):57-63. PubMed ID: 19241999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saccharomyces boulardii: a summary of the evidence for gastroenterology clinical practice in adults and children.
    Berni Canani R; Cucchiara S; Cuomo R; Pace F; Papale F
    Eur Rev Med Pharmacol Sci; 2011 Jul; 15(7):809-22. PubMed ID: 21780551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Saccharomyces boulardii fungemia. Apropos of a case].
    Zunic P; Lacotte J; Pegoix M; Buteux G; Leroy G; Mosquet B; Moulin M
    Therapie; 1991; 46(6):498-9. PubMed ID: 1819157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.